TDP1 Human, Sf9

Tyrosyl-DNA Phosphodiesterase 1 Human Recombinant, Sf9
Cat. No.
BT16457
Source
Sf9, Baculovirus cells.
Synonyms

Tyrosyl-DNA phosphodiesterase 1, Tyr-DNA phosphodiesterase 1, TDP1, FLJ11090, MGC104252.

Appearance
Sterile Filtered clear solution.
Purity

Greater than 90.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TDP1 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 617 amino acids (1-608) and having a molecular mass of 69.5kDa. TDP1 is fused to 6 amino acid His-Tag at C-terminus and purified by proprietary chromatographic techniques. 

Product Specs

Introduction
TDP1, a member of the phospholipase D family, plays a crucial role in DNA repair. It contains two PLD phosphodiesterase domains that enable it to repair stalled topoisomerase I-DNA complexes. This repair process involves hydrolyzing the phosphodiester bond between the tyrosine residue of topoisomerase I and the 3-prime phosphate of DNA. TDP1 may also be involved in repairing free-radical mediated DNA double-strand breaks by removing glycolate from single-stranded DNA containing 3-prime phosphoglycolate. Mutations in the TDP1 gene are associated with spinocerebellar ataxia with axonal neuropathy (SCAN1).
Description
Recombinant human TDP1, expressed in Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain. It consists of 617 amino acids (1-608) with a molecular mass of 69.5kDa. This protein is fused to a 6 amino acid His-Tag at the C-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
The TDP1 protein solution is supplied at a concentration of 0.25mg/ml in Phosphate Buffered Saline (pH 7.4) with 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 90.0% by SDS-PAGE analysis.
Synonyms

Tyrosyl-DNA phosphodiesterase 1, Tyr-DNA phosphodiesterase 1, TDP1, FLJ11090, MGC104252.

Source
Sf9, Baculovirus cells.
Amino Acid Sequence

ADPMSQEGDY GRWTISSSDE SEEEKPKPDK PSTSSLLCAR QGAANEPRYT CSEAQKAAHK RKISPVKFSN TDSVLPPKRQ KSGSQEDLGW CLSSSDDELQ PEMPQKQAEK VVIKKEKDIS APNDGTAQRT ENHGAPACHR LKEEEDEYET SGEGQDIWDM LDKGNPFQFY LTRVSGVKPK YNSGALHIKD ILSPLFGTLV SSAQFNYCFD VDWLVKQYPP EFRKKPILLV HGDKREAKAH LHAQAKPYEN ISLCQAKLDI AFGTHHTKMM LLLYEEGLRV VIHTSNLIHA DWHQKTQGIW LSPLYPRIAD GTHKSGESPT HFKADLISYL MAYNAPSLKE WIDVIHKHDL SETNVYLIGS TPGRFQGSQK DNWGHFRLKK LLKDHASSMP NAESWPVVGQ FSSVGSLGAD ESKWLCSEFK ESMLTLGKES KTPGKSSVPL YLIYPSVENV RTSLEGYPAG GSLPYSIQTA EKQNWLHSYF HKWSAETSGR SNAMPHIKTY MRPSPDFSKI AWFLVTSANL SKAAWGALEK NGTQLMIRSY ELGVLFLPSA FGLDSFKVKQ KFFAGSQEPM ATFPVPYDLP PELYGSKDRP WIWNIPYVKA PDTHGNMWVP SHHHHHH.

Product Science Overview

Structure and Function

TDP1 belongs to the phospholipase D family and contains two PLD phosphodiesterase domains . The enzyme’s primary function is to repair topoisomerase I-mediated DNA damage by catalyzing the hydrolysis of the phosphodiester bond . This activity is critical for maintaining genomic stability and preventing the accumulation of DNA damage that can lead to various diseases, including cancer .

Recombinant Production in Sf9 Cells

The recombinant form of TDP1, produced in Sf9 cells, is used for research and therapeutic purposes. Sf9 cells, derived from the fall armyworm (Spodoptera frugiperda), are commonly used in the baculovirus expression system for producing recombinant proteins . This system allows for high-level expression of functional proteins with post-translational modifications similar to those in higher eukaryotes .

Clinical Significance

Mutations in the TDP1 gene are associated with spinocerebellar ataxia with axonal neuropathy (SCAN1), a rare neurodegenerative disorder . This disease is characterized by progressive ataxia, peripheral neuropathy, and other neurological symptoms . Understanding the function and regulation of TDP1 is crucial for developing potential therapeutic strategies for SCAN1 and other conditions involving DNA damage and repair .

Research and Therapeutic Applications

TDP1 is a target for developing new chemosensitizing agents due to its role in repairing DNA damage caused by topoisomerase I poisons such as topotecan and irinotecan . Inhibitors of TDP1 are being explored as potential therapeutic agents to enhance the efficacy of these chemotherapeutic drugs .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.